Welcome to the 13th Annual World Clinical Biomarkers & CDx Summit
The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returned as the only industry-led meeting uniting 500+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement, and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.
Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads, and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.
Snapshot of Our 2023 Expert Speaker Faculty:
Senior Director, Global Regulatory Affairs, Precision Medicine Diagnostics
Vice President, Translational Science & Oncology
Senior Analyst - Research, Medical Policy & Technology Evaluation
Independence Blue Cross
SENIOR STAFF FELLOW
Executive Director & Head, CDx & Laboratory Operations
Vice President, Translational Medicine & Bioinformatics